Expand ALNY Menu
ALNY MENU

ALNY Latest Press Releases

-- April 18, 2024 --

Alnylam to Webcast Conference Call Discussing First Quarter 2024 Financial Results Business Wire 8:00 AM

-- April 7, 2024 --

Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standard of Care Antihypertensives in Patients with Inadequately Controlled Hypertension Business Wire 8:00 AM

-- March 20, 2024 --

Alnylam to Webcast Investor Event to Discuss Results from KARDIA-2 Phase 2 Study of Zilebesiran at American College of Cardiology Scientific Session Business Wire 8:00 AM

-- March 13, 2024 --

Alnylam Launches Hereditary ATTR (hATTR) Amyloidosis Campaign to Help Shorten Time to Diagnosis for Inherited and Rapidly Progressive Disease Business Wire 7:30 AM

-- March 11, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNY PRNewswire 7:30 PM

-- March 7, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNY Globe Newswire 4:02 PM

-- March 5, 2024 --

ByHeart Appoints Amy Schulman as Chair of the Board of Directors, Further Solidifying its Position as a Leader in the Infant Nutrition Category PRNewswire 9:07 AM
Alnylam Reports Positive KARDIA-2 Topline Study Results Demonstrating Clinically Significant Blood Pressure Reductions When Zilebesiran is Added to Standard of Care Antihypertensives Business Wire 7:30 AM

-- March 3, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNY PRNewswire 10:15 AM

-- February 28, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNY Globe Newswire 3:12 PM

-- February 27, 2024 --

Alnylam to Webcast Presentations at Upcoming March Investor Conferences Business Wire 8:30 AM

-- February 15, 2024 --

Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Period Activity Business Wire 8:00 AM

-- January 29, 2024 --

Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2023 Financial Results Business Wire 8:00 AM

-- January 9, 2024 --

Alnylam CEO Yvonne Greenstreet Named 2024 Woman of the Year by Healthcare Businesswomen's Association Business Wire 8:05 AM

-- January 7, 2024 --

Alnylam Announces Preliminary* Fourth Quarter and Full Year 2023 Global Net Product Revenues and Provides Additional Updates Business Wire 6:00 PM

-- January 2, 2024 --

Alnylam to Webcast Presentation at 42nd Annual J.P. Morgan Healthcare Conference Business Wire 7:30 AM

-- December 13, 2023 --

Alnylam Highlights Significant Progress with Platform Innovation and Clinical Pipeline at R&D Day Business Wire 7:30 AM

-- December 6, 2023 --

Alnylam to Webcast Virtual R&D Day Business Wire 8:00 AM

-- November 30, 2023 --

Alnylam Ranks #1 on Boston Globe's Top Places to Work List for 2023 Business Wire 8:00 AM